RayzeBio

Neumora Therapeutics, RayzeBio, initial public offering, Emerging Biopharma

RayzeBio and Neumora raise over $500M combined in successful IPOs for cancer therapies

Anika Sharma

Closing the week on an optimistic note, two biotech IPOs have successfully crossed the finish line with impressive results. RayzeBio, ...